Expanding the Reach of Care for Cancer and Other Disease States: BAMF Health and GE HealthCare collaborate to enable sustainable and scalable solutions for growth in Theranostics
November 13 2023 - 9:00AM
Business Wire
- Long-term relationship will focus on the potential for new
advancements to expand patient and clinician access and transform
the approach to discovery, diagnosis, and treatment of cancer and
other disease states.
As demand for Theranostic care increases, GE HealthCare and BAMF
Health are excited to announce a collaboration aimed at enabling
BAMF Health to scale turnkey offerings inclusive of leading GE
HealthCare technologies and services. The goal of the collaboration
is to ensure an agile go-to-market approach to enhance the adoption
of Theranostics solutions in the U.S. The arrangement supports a
shared interest in better patient outcomes made possible through
advanced diagnostics and radiotherapeutics.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20231113120193/en/
Theranostics in molecular imaging uses both imaging technology
and targeted therapies to identify and treat diseases such as
cancer as well monitor response to treatment; the term originates
from the way this form of personalized medicine is practiced – the
combination of therapy and diagnostics.
“The targeted nature of Theranostics has begun showing crucial
improvements in personalized care for patients battling complex
cancers and we see vast opportunities for additional care areas
such as Alzheimer's disease,” Said BAMF Health founder and CEO, Dr.
Anthony Chang. “This new way of working together with GE HealthCare
will allow us to drive innovation in this fast-moving space.”
Connecting all phases of the Theranostics care pathway, from
drug development through disease diagnosis and treatment
monitoring, with scalable solutions, connectivity, and advanced
imaging technologies, is critical to helping clinicians and health
systems bring Theranostics treatments to more patients. The
collaboration between GE HealthCare and BAMF Health will leverage
both partners’ deep understanding of the complexities of delivering
Theranostic care to establish a framework to support the scalable
infrastructure and clinical solutions for expanded adoption of
precision care.
“GE HealthCare’s holistic approach to Theranostics brings
together critical teams, data and decision-making needed to deliver
precise, personalized care for patients,” shares Catherine
Estrampes, president and CEO, GE HealthCare in U.S. and Canada.
“Together with BAMF Health we are thrilled to draw upon our shared
expertise to advance the adoption and integration of Theranostics
care.”
As the only healthcare industry partner with solutions spanning
from cyclotrons, chemistry synthesis, pharmaceutical diagnostics,
PET/CT, PET/MR, SPECT/CT, and advanced oncology and digital
solutions, GE HealthCare is uniquely positioned to cover the full
breadth of the patient care journey. BAMF Health is similarly
positioned to advance the practice of Theranostics by utilizing
their expertise to partner with health systems across the country
to scale molecular imaging and Theranostics, making this new
treatment affordable to patients and accessible to clinicians.
About BAMF Health
BAMF Health has created the world’s first vertically integrated
platform for Intelligence Based Precision Medicine through
AI-enabled Molecular Imaging and Theranostics. Our approach focuses
on intelligence-based treatment. Our state-of-the-art platform
allows us to see what we treat - and treat what we see. We help
patients spend less time in the hospital, feel better faster, and
simply get back to living their life.
To learn more about Theranostics at BAMF Health, visit
www.bamfhealth.com, and follow on Facebook and LinkedIn.
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global medical technology,
pharmaceutical diagnostics, and digital solutions innovator,
dedicated to providing integrated solutions, services, and data
analytics to make hospitals more efficient, clinicians more
effective, therapies more precise, and patients healthier and
happier. Serving patients and providers for more than 100 years, GE
HealthCare is advancing personalized, connected, and compassionate
care, while simplifying the patient’s journey across the care
pathway. Together our Imaging, Ultrasound, Patient Care Solutions,
and Pharmaceutical Diagnostics businesses help improve patient care
from diagnosis, to therapy, to monitoring. We are an $18.3 billion
business with 50,000 employees working to create a world where
healthcare has no limits.
Follow us on Facebook, LinkedIn, Twitter, Instagram, and
Insights for the latest news, or visit our website
https://www.gehealthcare.com/ for more information.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231113120193/en/
GE HealthCare Media Contact Caitlin Lamey M +1 951 249
1401 Caitlin.Lamey@ge.com
BAMF Health Media Contact Andy McLean
Andy.mclean@bamfhealth.com
GE HealthCare Technologies (NASDAQ:GEHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
GE HealthCare Technologies (NASDAQ:GEHC)
Historical Stock Chart
From Jul 2023 to Jul 2024